Skip to Content

K U 712 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg)

Pill with imprint K U 712 is Yellow, Figure eight-shape and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg. It is supplied by Cobalt Laboratories Inc.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for K U 712

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg K U 712
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg K U 712
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg K U 712

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint
K U 712
Strength
12.5 mg / 7.5 mg
Color
Yellow
Size
11.00 mm
Shape
Figure eight-shape
Availability
Prescription only
Drug Class
ACE inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cobalt Laboratories Inc
National Drug Code (NDC)
16252-0612

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.